Herceptin plus chemo increases gastric cancer survival

01/27/2010 | MedPage Today (free registration)

Adding trastuzumab, or Herceptin, to chemotherapy for patients with advanced HER2-positive gastric cancer increases survival without a decline in quality of life, a study found. Researchers said pain scores and use of analgesics were similar between patients who received chemotherapy with or without trastuzumab.

View Full Article in:

MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Director, Quality Regulatory Affairs
Cardinal Health
Chicago, IL
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC